Published by Gbaf News
Posted on June 15, 2020
5 min readLast updated: January 21, 2026
Healix International combines cutting edge technology with best in class medical and risk intelligence for highest levels of duty of care
While the debate continues about ‘air bridges’ to open up international travel between certain countries, there is a clear imperative for business to re-open around the world. But for many organisations the big issue is how to keep employees safe and well while simultaneously resuming global operations and maintaining profitability.
“Businesses cannot operate via virtual conference tools forever; business critical travel needs to resume, and for many, that needs to happen now”, commented Mike Webb, CEO of Healix International. “However, employee expectations and legislation have drastically changed in the wake of COVID-19 and organisations across every industry are faced with the difficulty of demonstrating their duty of care obligations to their employees in an incredibly complex operating environment, particularly when it comes to weighing up the risks of international travel.
“COVID-19 has turned the entire concept of travel risk on its head. For the first time in a generation, risk is highest in parts of the world that have historically been considered the safest, and these countries account for more than 90% of global business travel. Logistical and operational restrictions across the world are changing by the day. And information related to COVID-19 and necessary measures to reduce transmission remains vast, ambiguous, highly complex and often incomplete. Even the most well-resourced organisations are struggling to stay on top of the magnitude of information that is published each day.”
In response Healix International is launching ‘COVID Travel Safe’. This one-of-a-kind product is a layered risk assessment tool that has been designed to enable business travel within a pandemic, and to provide instant assessments of the medical and logistical risks posed by each and every unique proposed travel itinerary.
Healix International Chief Medical Officer, Dr Adrian Hyzler explained: “We know that in this incredibly challenging time, all businesses need to be supported in resuming operations and providing an increased duty of care to their travellers. This tool allows any organisation to have the confidence to deploy employees safely and with the knowledge that those travelling do not pose a high medical risk of severe disease.”
The ‘COVID Travel Safe’ tool works to protect employees and organisations as follows:
LAYER 1: ‘COVID Travel Safe’ online tool
The platform experience begins with the user answering a number of questions about their intended trip alongside a COVID-19 specific medical questionnaire. The ‘COVID Travel Safe’ tool will then generate a medical risk assessment. This assessment combines information about an individual’s medical risks with data around the local pandemic conditions and logistical factors in the country of destination. This information is incorporated into an instantly available risk assessment document that the traveller can download.
Healix International’s unique methodology measures a range of sub-risk factors including pandemic trend and COVID testing access, alongside practical concerns such as travel bans and curfews. Developed in-house by the Healix International panel of medical experts, the online tool calculates a medical ‘risk score’ for each individual. Behind the scenes, Healix International’s team of medical and risk professionals closely monitor the science, government restrictions and logistical risk environments around the world. This ensures that the information driving ‘COVID Travel Safe’ is up to date and representative of the pandemic’s evolution.
The online tool will provide an automated summary assessment of whether the traveller should proceed with their intended trip. This determination is delivered in the form of a ‘traffic light’ system of Red, Amber and Green. In the event that the traveller receives a Red assessment, risk factors warrant the individual reconsidering their need to travel. ‘Green’ indicates that the tool has not identified any major concerns with the intended trip, therefore booking can proceed. In the case of an ‘Amber’ result, a follow up consultation with Healix International’s medical and/or logistical risk teams is recommended.
LAYER 2: Personal Assessment
For those travellers who flag as ‘Amber’ there is the option to automatically integrate an escalation to the Healix International in-house medical and logistical risk teams for a personal assessment. The company’s experts can review the report and provide customised advice on the associated risks. This advice then enables the traveller to make a more informed decision about the medical risks and the potential logistical complications. If required, Healix International can also work with employees to arrange pre-deployment COVID-19 tests and navigate unique logistical complexities. This layered approach provides the convenience of an easy-to-use online tool, seamlessly integrated with a more personalised expert service.
Further Customisation
The ‘COVID Travel Safe’ tool is highly customisable and able to sit on an organisation’s own systems, conveniently integrating the risk assessment and trip approval workflow. Risk managers are given access to a separate login that allows them to track the requests and manage traveller support services where required. Healix International is also able to integrate travel policy rules, manager approvals, security information and ground support request forms to ensure that travellers can transition through the entire risk assessment and approval process in one efficient visit.
This is a Sponsored Feature
Explore more articles in the Technology category
